Chicago, IL, United States of America

John R Asplin

USPTO Granted Patents = 10 


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: John R. Asplin: Innovator in Clinical Laboratory Management

Introduction

John R. Asplin is a notable inventor based in Chicago, IL (US), recognized for his contributions to clinical laboratory-based disease management. With a total of 10 patents, Asplin has made significant strides in developing automated patient-specific treatment advice systems.

Latest Patents

One of Asplin's latest patents is a clinical laboratory-based disease management program that includes automated patient-specific treatment advice. This innovative method involves receiving test result data from physical specimens and associating it with standard-of-care data. The standard-of-care data represents a recommended course of action for the condition indicated by the test results. The system transforms this data into a human-readable format, enhancing the usability of the information for healthcare providers.

Career Highlights

Throughout his career, John R. Asplin has worked with prestigious institutions such as New York University and The General Hospital Corporation. His work has focused on improving clinical practices through innovative technological solutions.

Collaborations

Asplin has collaborated with notable professionals in the field, including Fredric L. Coe and David Goldfarb. These collaborations have contributed to the advancement of clinical laboratory practices and patient care.

Conclusion

John R. Asplin's work in clinical laboratory management exemplifies the impact of innovation in healthcare. His patents and collaborations continue to influence the field, paving the way for improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…